Veriti Management LLC Repligen Corp Transaction History

Veriti Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	BUY	$140.68 - $188.02 $1,406 - $1,880	10 Added 0.64%	1,569 $255,000
Q1 2022 Apr 11, 2022	BUY	$161.19 - $257.96 $108,642 - $173,865	674 Added 76.16%	1,559 $293,000
Q4 2021 Jan 19, 2022	SELL	$247.59 - $304.47 $18,321 - $22,530	-74 Reduced 7.72%	885 $234,000
Q3 2021 Oct 08, 2021	SELL	$194.77 - $324.21 $48,692 - $81,052	-250 Reduced 20.68%	959 $277,000
Q2 2021 Jul 13, 2021	BUY	$165.87 - $220.95 $18,079 - $24,083	109 Added 9.91%	1,209 $241,000
Q1 2021 Apr 14, 2021	SELL	$180.37 - $226.26 $28,678 - $35,975	-159 Reduced 12.63%	1,100 $214,000
Q4 2020 Feb 11, 2021	BUY	$148.08 - $206.57 $186,432 - $260,071	1,259 New	1,259 $241,000

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Veriti Management LLC, based on Form 13F filings with the SEC.

Stay updated on Veriti Management LLC with notifications on news.